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Abstract
Background: Hip fractures are common in elderly patients, in whom it is important to monitor blood loss;
however, unnecessary transfusions should be avoided. The primary objective of this study was to assess whether
the employment of a dedicated orthogeriatrician in an Orthopaedic Department allows to optimise the clinical
conditions of patients, influencing blood loss and consequently the number of transfusions. The secondary
objective was to determine whether the influence of the orthogeriatrician differs according to the type of surgical
treatment.
Methods: A total of 620 elderly patients treated for hip fracture were included in the study. These patients were
divided into two groups according to the presence or not of the orthogeriatrician. For each patient, age, sex,
comorbidities, type of fracture, surgical treatment, length of hospital stay, time from hospitalisation and surgery,
time from surgery to discharge, haemoglobin (Hb) values (admission, 24h post-surgery, lowest Hb reached,
discharge) and the number of transfusions were recorded.
Results: Regardless of the surgical procedure performed, in patients managed by the orthogeriatrician, the Hb at
discharge was significantly higher (p = 0.003). In addition to the highest Hb at discharge, in patients who
underwent hemiarthroplasty, the number of transfusions per patient is significantly reduced (p = 0.03).
Conclusion: The introduction of the orthogeriatrician in an orthopaedic ward for the management of elderly
patients treated for hip fracture allows to discharge the patients with higher Hb values, reducing the risk of
anemisation and the costs related to possible re-admission.
Keywords: Haemoglobin, Transfusions, Orthogeriatrician, Hip fractures, Elderly patients, Interdisciplinary
management
Introduction
Hip fractures are common in elderly patients [1–6].
They can be classified as medial, or intracapsular frac-
tures, related to an increased risk of osteonecrosis of the
femoral head [7–12] and lateral, or extracapsular
fractures [13–16]. The main risk factor for hip fractures
is osteoporosis [2, 17–20]. Type II osteoporosis, which is
age-related, is a risk factor for both female and male pa-
tients [2, 17, 18, 20]; type I, postmenopausal, is respon-
sible for the increased incidence of hip fractures in
female patients [21–23]. Most patients report an acci-
dental fall, often the result of a bone failure related to
advanced osteoporosis [1, 2, 4, 6]. These patients often
have comorbidities, especially cardiovascular [1, 4, 16,
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24–26]. In patients with hip fractures, it is important to
monitor blood loss caused by both trauma and subse-
quent surgical treatment. Therefore, it is necessary to
constantly examine laboratory tests, such as haematocrit
and haemoglobin (Hb), so as to intervene promptly with
blood transfusions to restore acceptable values [27–30].
However, unnecessary transfusions should be avoided
because they represent both a risk factor for adverse out-
comes and unjustified expenditure [27–30]. In this per-
spective, a close collaboration between orthopaedic and
orthogeriatrician may provide both clinical and eco-
nomic advantages. The orthogeriatrician plays a crucial
role enhancing and stabilising medical conditions to
allow faster access to the actual surgery and reduce the
postoperative length of the hospital stay [2].
The primary objective of the present study is to assess
whether, in the interdisciplinary management of elderly
patients with hip fracture, the employment of a dedi-
cated orthogeriatrician allows to optimise the clinical
conditions of patients, influencing blood loss and conse-
quently the number of transfusions. The secondary ob-
jective was to determine whether the influence of the
orthogeriatrician differs according to the type of surgical
treatment: cephalomedullary nail, hip hemiarthroplasty
(HHA) or total hip arthroplasty (THA).
Materials and methods
Study design
Data were collected from the Academic Department of
Trauma and Orthopaedics of the San Giovanni di Dio e
Ruggi d’Aragona Hospital of Salerno database. Data were
collected for elderly patients undergoing hip fracture
surgery for 2 years. From February 1, 2017, to January
31, 2018, before a dedicated orthogeriatrician started to
work in the department; and from February 1, 2018, to
January 31, 2019, with the employment of the orthoger-
iatrician in the department. The inclusion criteria were
age ≥ 65, intra- and extra-capsular femoral fractures, fra-
gility fractures and low energy trauma. Patients < 65
years with hip fractures resulting from high-energy
trauma and/or pathological fractures were excluded.
Considering the inclusion and exclusion criteria, a total
of 620 patients were included in the study. These pa-
tients were divided into two groups according to the
presence or not of the orthogeriatrician: 296 patients
were included in the Pre-O group (February 1, 2017–
January 31, 2018), and 324 patients in the Post-O group
(February 1, 2018–January 31, 2019). Two orthopaedic
residents worked on data collection and statistical ana-
lysis. For each patient, we recorded age, sex, comorbidi-
ties, type of fracture (intra/extra-capsular), surgical
treatment performed, length of hospital stay (LOS), time
from hospitalisation and surgery, time from surgery to
discharge, haemoglobin (Hb) values (admission, 24h




Every day, each patient admitted is evaluated with the
close collaboration between the staff of the orthopaedic
surgeon and the orthogeriatrician. The orthogeriatrician
evaluates and manages the general health conditions of
the patients, while the orthopaedic deals with the clinical
and surgical aspects of the fracture. Following the evalu-
ation of laboratory parameters, management is reas-
sessed and changed if indicated. The levels of Hb are
followed to intervene promptly with transfusions, thus
avoiding the risk of anaemia. The threshold values of Hb
to start the transfusion are debated; often, the decision
to transfuse is related to the clinical conditions of pa-
tients and associated comorbidities and not to the actual
absolute value of haemoglobin concentration.
Statistical analysis
Descriptive statistic was used for data related to the
demographic characteristics of the two groups (mean,
range, standard deviation, and percentages). The statis-
tical analysis of continuous variables was performed
using the Student t test, while categorical variables were
analysed with the chi-square test. The test is considered
statistically significant if the p value is < 0.05.
Results
A total of 620 patients were identified and included in
the study; 479 (77.3%) were women and 141 (22.7%)
men. The average age was 83.85 years (SD 7.35; range
from 53 to 99 years). The Pre-O group includes 296
(47.7%) patients, 71 (23.9%) males and 225 (76.1%) fe-
males, with an average age of 84.1 years (SD 7.02; range
from 63 to 98). One hundred ninety-eight (66.89%) pa-
tients were managed surgically with a cephalomedullary
nail; 90 (30.41%) with HHA and the remaining 8 (2.7%)
patients with THA. The Post-O group includes 324
(52.26%) patients, 70 (21.6%) males and 254 (78.4%) fe-
males; the average age was 83.6 years (SD 7.64; range
from 53 to 99). In this group, 210 (64.81%) patients were
managed with a cephalomedullary nail, 97 (29.95%) with
HHA and 17 (5.24%) with THA.
Table 1 summarises the demographic characteristics of
the two groups.
Hb and transfusions
Analysing the values of Hb for each group, regardless of
the surgical procedure performed, we obtained data re-
ported in Table 2. No complications related to the blood
transfusions were recorded. The mean haemoglobin
values at admission did not differ statistically between
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the two groups (p = 0.9), with 11.96 mg/dL (SD 1.76;
range from 7 to 16.2) in the Pre-O group and 11.97 mg/
dL (SD 1.7; range from 5 to 18.2) in the Post-O group.
The day after surgery (24 h), the mean values of Hb de-
creased respectively to 9.43 mg/dL (SD 1.29; range from
5.7 to 13.5) and 9.56 mg/dL (SD 1.31; range from 5.6 to
14.6) (p = 0.21). The lowest Hb is achieved after 2.08
days (SD 2.02; range from −7 to 9) in the Pre-O group
with average values of 8.33 mg/dl (SD 0.95; range from
5.1 to 13.1); while in the Post-O group is reached after
1.96 days (SD 2.14; range from −12 to 13) with average
values of 8.42 mg/dL (SD 1; range from 3.5 to 13.1).
However, there are no significant differences related to
the day (p = 0.5) and the lowest Hb value reached (p =
0.3). There was a significant difference between the two
groups in the Hb at discharge (p = 0.003), with 10.07
mg/dl (SD 0.82; range from 8.2 to 13.3) in the Pre-O
group and 10.27 mg/dl (SD 0.84; range from 8.5 to 14.5)
Table 1 demographic characteristics of Pre-O and Post-O groups
Pre-orthogeriatrician Post-orthogeriatrician P value
Number of patients 296 324
Mean age (SD; range) 84.1 (SD 7.02; 63–98) 83.6 (SD 7.64; 53–99) 0.4
Sex 71 M; 225 F 70 M; 254 F
Cephalomedullary nail 198 (66.89%) 210 (64.81%) 0.56
HHA 90 (30.41%) 97 (29.95%) 0.9
THA 8 (2.70%) 17 (5.24%) 0.1
Length of hospital stay (mean days; SD; range) 11.84 (4.34; 5 to 45) 12.29 (4.49; 5 to 39) 0.2
Comorbidities
Diabetes 59 (19.93%) 73 (22.53%) 0.4
Hypertension 193 (65.2%) 213 (65.74%) 0.9
Atrial fibrillation 51 (17.23%) 61 (20.61%) 0.3
Heart failure 37 (12.5%) 20 (6.17%) 0.007 *
Myocardial infarction 21 (7.09%) 28 (8.64%) 0.5
Hypercholesterolaemia 33 (11.15%) 47 (14.51%) 0.2
Depression 14 (4.73%) 21 (6.48%) 0.3
TIA 29 (9.79%) 32 (9.87%) 0.9
COPD 30 (10.13%) 26 (8.02%) 0.4
CKD 25 (8.45%) 34 (10.49%) 0.4
Dementia 36 (12.16%) 39 (12.03%) 0.9
Alzheimer 11 (3.72%) 6 (1.85%) 0.2
Parkinson 12 (4.05%) 18 (5.55%) 0.4
Table 2 Hb and transfusions: Pre-O vs Post-O
Pre-O group Post-O group P value
Number of patients 296 324
Hb - admission (mg/dL; SD; range) 11.96 (1.76; 7 to 16.2) 11.97 (1.70; 5 to 18.2) 0.9
Hb 24 h post-surgery (mg/dL; SD; range) 9.43 (1.29; 5.7 to 13.5) 9.56 (1.31; 5.6 to 14.6) 0.2
Hb - discharge (mg/dL; SD; range) 10.07 (0.82; 8.2 to 13.3) 10.27 (0.84; 8.5 to 14.5) 0.003 *
Hb - lowest peak (mean; SD; range) 8.33 (0.95; 5.1 to 13.1) 8.42 (1; 3.5 to 13.1) 0.3
Post-surgery lowest peak day (mean; SD; range) 2.08 (2.02; −7 to 9) 1.96 (2.14; −12 to 13) 0.5
Total transfusions 541 551
Transfusions per patient (mean; SD; range) 1.84 (1.4; 0 to 8) 1.7 (1.46; 0 to 8) 0.2
Length of stay (mean; SD; range) 11.83 (4.34; 5 to 45) 12.29 (4.49; 5 to 39) 0.2
Pre-op days (mean; SD; range) 2.44 (2.34; 0 to 15) 2.32 (2.13; 0 to 21) 0.5
Post-op days (mean; SD; range) 9.38 (3.73; 0 to 43) 9.96 (4.01; 1 to 37) 0.06
*statistically significant
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in the Post-O group. A total of 541 transfusions were
performed in the Pre-o Group, with a mean of 1.84
(SD1.4; range from 0 to 8) transfusions per patient; 551
transfusions were performed in the Post-O group with a
mean of 1.7 (SD 1.46; range from 0 to 8) transfusions
per patient (p = 0.2). No significant difference was found
in relation to LOS, pre- and post-surgical days.
Hb and transfusion: cephalomedullary nail
The data on patients who underwent cephalomedullary
nailing are reported in Table 3. The Pre-O group includes
198 patients with an average age of 84.6 years (SD 6.52;
range from 65 to 98); the Post-O group includes 210 pa-
tients with a mean of 84.9 years (6.4; from 66 to 99) (p =
0.6). The mean Hb at admission was 11.73 mg/dL (SD
1.69; range from 7 to 15.6) in the Pre-O group and 11.61
mg/dL (SD 1.66; range from 5 to 15.3) in the Post-O
group (p = 0.5). Twenty-four hours after surgery, the Hb
was 9.21 mg/dl (SD 1.28; range from 5.7 to 13.5) and
9.25 mg/dL (SD 1.17; range from 5.6 to 13.1), re-
spectively (p = 0.7). Hb at discharge was 10.1 mg/dL
(SD 0.82; range from 8.2 to 9.9) in the Pre-O group
and 10.2 mg/dL (SD 0.8; range from 8.5 to 13.1) in
the Post-O group (p = 0.3). In the Pre-O group, the
lowest value of Hb is 1.9 days (SD 2.09; range from
−7 to 9) after surgery with an average of 8.31 mg/dl
(SD 0.94; range from 5.1 to 13.1); in the Post-O
group, it is 1.54 days (SD 2.17; range from −12 to 13)
later, with average values of 8.36 mg/dl (SD 1.02;
range from 3.5 to 12.5). Again, there are no signifi-
cant differences. The number of transfusions was 379
in the Pre-O group with a mean of 1.93 (SD 1.45;
range from 0 to 8) transfusions per patient; 393 in
the Post-O group with 1.87 (SD 1.56; range from 0 to
8) transfusions per patient (p = 0.7).
Hb and transfusions: HHA
The data related to patients who underwent hemiarthro-
plasty (HHA) are reported in Table 4. The Pre-O group
includes 90 patients with a mean age of 83.8 years (SD
7.2; range from 65 to 96); the Post-O group included 97
patients with a mean age of 82.5 years (SD 7.96; range
from 55 to 99) (p = 0.2). Hb at admission was 12.36 mg/
dL (SD 1.85; range from 8 to 16.2) in the Pre-O group
and 12.61 mg/dL (SD 1.56; range from 8.8 to 18.2) in
the Post-O group (p = 0.31). Twenty-four hours after
surgery, the Hb did not differ significantly between the
two groups (p = 0.1). In these patients, the Hb at dis-
charge differs significantly in the two groups (p =
0.0001), 9.96 mg/dL (SD 0.82; range from 8.6 to 9.4) in
the Pre-O group and 10.43 mg/dL (SD 0.8; range from
8.9 to 12.9) in the Post-O group. In the Pre-O group,
the lowest peak of Hb is 8.39 mg/dl (SD 0.97; range from
6 to 11.5), reached 2.43 days (SD 1.84; range from −7 to
9) after surgery, while in the Post-O group is 8.62 mg/dl
(SD 0.9; range from 6.5 to 10.9), 2.71 days (SD 1.92;
range from −5 to 11) after surgery. A further significant
difference is the average number of transfusions per pa-
tient (p = 0.03). Indeed, 153 transfusions were performed
in the Pre-O group with an average of 1.7 (SD 1.31;
range from 0 to 6) transfusions per patient; in the Post-
O group 127 transfusions were performed with an aver-
age of 1.31 (SD 1.13; range from 0 to 6) transfusions per
patient. In these patients, the LOS and the pre-surgery
days do not differ, while in the Pre-O group, the time
between surgery and discharge is significantly reduced (p
= 0.008).
Hb and transfusion: THA
In patients undergoing THA, there are no significant dif-
ferences between the two groups (Table 5). The Pre-O
Table 3 Cephalomedullary nail
NAIL Pre-O group Post-O group P value
Number of patients 198 210
Age (mean; SD; range) 84.6 (6.52; from 65 to 98) 84.9 (6.4; from 66 to 99) 0.6
Sex 36 M; 162 F 44 M; 166 F
Hb - admission (mg/dL; SD; range) 11.73 (1.69; 7 to 15.6) 11.61 (1.66; 5 to 15.3) 0.5
Hb 24 h post-surgery (mg/dL; SD; range) 9.21 (1.28; 5.7 to 13.5) 9.25 (1.17; 5.6 to 13.1) 0.7
Hb - discharge (mg/dL; SD; range) 10.11 (0.82; 8.2 to 9.9) 10.2 (0.8; 8.5 to 13.1) 0.3
Hb - lowest peak (mean; SD; range) 8.31 (0.94; 5.1 to 13.1) 8.36 (1.02; 3.5 to 12.5) 0.6
Post-surgery lowest peak day (mean; SD; range) 1.9 (2.09; -7 to 9) 1.54 (2.17; -12 to 13) 0.09
Total transfusions 379 393
Transfusions per patient (mean; SD; range) 1.93 (1.45; 0 to 8) 1.87 (1.56; 0 to 8) 0.7
Length of stay (mean; SD; range) 11.83 (4.34; 5 to 45) 12.29 (4.49; 5 to 39) 0.2
Pre-op day (mean; SD; range) 2.44 (2.34; 0 to 15) 2.32 (2.13; 0 to 21) 0.5
Post-op day (mean; SD; range) 9.38 (3.73; 0 to 43) 9.96 (4.01; 1 to 37) 0.06
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group includes 8 patients with a mean age of 74 years
(SD 7.38; range from 63 to 87); the Post-O group com-
prises 17 patients with an average age of 72 years (SD
9.5; range from 53 to 93) (p = 0.6). Hb on admission was
13.52 mg/dL (SD 0.94; range from 11.5 to 14.7) in the
Pre-O group; 12.94 mg/dL (SD 1.68; range from 10.3 to
15.8) in the Post-O group (p = 0.37). Twenty-four hours
after THA, Hb was 10.62 mg/dL (SD 0.61; range from
10 to 11.6) and 10.16 mg/dL (SD 1.35; range from 7.8 to
12.6), respectively (p = 0.4). On discharge, the values
were 10.23 mg/dl (SD 0.68; range from 9.5 to 11.8) for
the Pre-O group and 10.36 mg/dl (SD 1.37; range from
8.7 to 14.5) with for the Post-O group. The lowest level
of Hb was 3.17 days (SD 1.6; range from 2 to 6) after
surgery, with 8.57 mg/dL (SD 0.58; range from 7.7 to
9.3) in the Pre-O group; and after 2.87 days (SD 1.75;
range from 0 to 11) with 8.1 mg/dL (SD 0.86; range from
6.4 to 9.7) in the Post-O group (p = 0.7). The patients of
the Pre-O group received a total of 9 transfusions, 1.12
(SD 0.64; range from 0 to 2) transfusions per patient; 31
transfusion were performed in the Post-O group, 1.82
(SD 1.42; range from 0 to 5) transfusions per patient (p
= 0.12).
Discussion
A significant health care burden is related to the man-
agement of elderly patients with hip fractures [31–33].
Indeed, the incidence of hip fractures, as well as the inci-
dence of all age-related fractures, is progressively in-
creasing given the increase of life expectancy [31, 33–
35]. Treating the fracture is not enough, and a compre-
hensive management of the patient is needed. Multiple
Table 4 HHA
HHA Pre-O group Post-O group P value
Number of patients 90 97
Age (mean; SD; range) 83.8 (7.2; from 65 to 96) 82.5 (7.96; from 55 to 99) 0.2
Sex 33 M; 57 F 20 M; 77 F
Hb - admission (mg/dL; SD; range) 12.36 (1.85; 8 to 16.2) 12.61 (1.56; 8.8 to 18.2) 0.3
Hb 24 h post-surgery (mg/dL; SD; range) 9.84 (1.21; 7.2 to 13.2) 10.13 (1.37; 7.4 to 14.6) 0.1
Hb - discharge (mg/dL; SD; range) 9.96 (0.82; 8.6 to 9.4) 10.43 (0.8; 8.9 to 12.9) 0.0001*
Hb - lowest peak (mean; SD; range) 8.39 (0.97; 6 to 11.5) 8.62 (0.9; 6.5 to 10.9) 0.09
Post-surgery lowest peak day (mean; SD; range) 2.43 (1.84; −7 to 9) 2.71 (1.92; −5 to 11) 0.3
Total transfusions 153 127
Transfusions per patient (mean; SD; range) 1.7 (1.31; 0 to 6) 1.31 (1.13; 0 to 6) 0.03*
Length of stay (mean; SD; range) 11.78 (3.93; 7 to 25) 12.77 (5.03; 6 to 39) 0.1
Pre-op day (mean; SD; range) 3.02 (2.78; 0 to 15) 2.49 (2.25; 0 to 16) 0.2
Post-op day (mean; SD; range) 8.75 (2.72; 4 to 17) 10.27(4.66; 1 to 37) 0.008*
*statistically significant
Table 5 THA
THA Pre-O group Post-O group P value
Number of patients 8 17
Age (mean; SD; range) 74 (7.38; from 63 to 87) 72 (9.5; from 53 to 93) 0.6
Sex 2 M; 6 F 6 M; 11 F
Hb - admission (mg/dL; SD; range) 13.52 (0.94; 11.5 to 14.7) 12.94 (1.68; 10.3 to 15.8) 0.4
Hb 24 h post-surgery (mg/dL; SD; range) 10.62 (0.61; 10 to 11.6) 10.16 (1.35; 7.8 to 12.6) 0.4
Hb - discharge (mg/dL; SD; range) 10.23 (0.68; 9.5 to 11.8) 10.36 (1.37; 8.7 to 14.5) 0.8
Hb - lowest peak (mean; SD; range) 8.57 (0.58; 7.7 to 9.3) 8.1 (0.86; 6.4 to 9.7) 0.2
Post-surgery lowest peak day (mean; SD; range) 3.17 (1.6; 2 to 6) 2.87 (1.75; 0 to 11) 0.7
Total transfusions 9 31
Transfusions per patient (mean; SD; range) 1.12 (0.64; 0 to 2) 1.82 (1.42; 0 to 5) 0.2
Length of stay (mean; SD; range) 10.71 (2.42; 9 to 16) 13.76 (6.8; 7 to 34) 0.2
Pre-op day (mean; SD; range) 1.42 (0.53; 1 to 2) 2.64 (1.65; 1 to 7) 0.06
Post-op day (mean; SD; range) 9.28 (2.28; 7 to 14) 11.12 (6.2; 5 to 27) 0.4
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comorbidities in the elderly population are extremely
common [36, 37]. Consequently, these patients take
multi-therapies that need to be considered before ad-
ministering further drugs [36, 37].
In elderly patients with a hip fracture, it is important
to monitor blood loss; they are often anaemic, regardless
of the fracture [38]. Anaemia may delay surgical treat-
ment, resulting in further blood loss. In these patients,
transfusions are needed. However, the threshold value of
Hb to begin the transfusion is debated. Some studies re-
port that, in such patients, transfusions are associated
with an increased risk of post-surgical complications and
long-term mortality [39]; others report a decreased rate
of delirium and a faster post-surgical functional recovery
[40–42]. In others still, no association between the num-
ber of transfusions and the risk of mortality is recog-
nised [43]. Some studies proposed a threshold value of
Hb < 7 mg/dL as a trigger for transfusions in
hemodynamically stable patients [44]. However, elderly
patients with hip fractures often have different comor-
bidities, especially cardiovascular; in addition, it must
also be considered the age-related fragility of these pa-
tients, in whom the fracture can lead to rapid
hemodynamic imbalance even if they may be initially
stable. In the Orthopaedic Department of the San Gio-
vanni di Dio e Ruggi d’Aragona Hospital of Salerno, pa-
tients are monitored every day to maintain Hb to
adequate levels. Since February 1, 2018, an orthogeriatri-
cian works in the Orthopaedic Department, to promote
functional recovery, reducing pre- and post-surgical
complications and both short- and long-term mortality
of the patients, thus reducing LOS, re-hospitalisations
and related costs [45, 46]. The present study assessed
whether the presence of an orthogeriatrician affects the
blood management and the number of transfusions in
patients with hip fractures. Regardless of the surgical
treatment performed, there are no significant differences
related to Hb at admission and 24 h after surgery, and
the number of transfusions per patient does not differ
significantly despite the involvement of the
orthogeriatrician.
However, Hb at discharge was significantly higher in
the Post-O group (p = 0.003). This difference probably
results from a more comprehensive management pro-
vided by the orthogeriatrician, which also allows a faster
recovery of the values of the Hb. Analysing the data ac-
cording to the surgical procedure performed, there are
some differences. Indeed, there are no differences related
to Hb levels and the number of transfusions in the pa-
tients treated with an intramedullary nail and with THA.
Differently, in the patients undergoing HHA, Hb at dis-
charge was significantly higher in the patients managed
by the orthogeriatrician (p = 0.0001); in addition, in
these patients, the number of transfusions per patient
was reduced (p = 0.03), although the post-surgical LOS
was increased (p = 0.008). Despite the lack of significant
differences in the number of transfusions performed, the
higher Hb value at discharge may have a significant im-
pact. Low levels of Hb can increase the LOS and thus
hospital-related costs. In addition, although the risk of
morbidity and mortality may not be affected, higher
values of Hb at discharge reduce the risk of re-
admission [47]. This allows to prevent further costs re-
lated to both the hospitalisation and the need for trans-
fusions in case of hemodynamic imbalance of patients,
in particular those with associated cardiovascular
diseases.
The strength of this study is related to a large number
of patients included. The demographic characteristics of
patients and comorbidities do not differ significantly, ex-
cept for patients with heart failure, who presented less
often in the Post-O period (p = 0.007). In addition, the
surgical procedures were performed in both groups by
the same surgical team; therefore, the experience of sur-
geons should not affect the outcomes. The limitations
are related to the retrospective nature of the study. The
included patients were at least ASA III, as assessed by a
consultant anaesthetist with a special interest in hip frac-
ture management in the elderly. The computerised data
collection and retrieval system in our health care system
does not allow us to dwell further in this field; this
would have made it possible to define more precisely the
work of the orthogeriatrician. Furthermore, no data are
available on the patient after discharge, so it is not pos-
sible to assess the long-term outcomes of the two groups
of patients.
Conclusion
The introduction of the orthogeriatrician in an ortho-
paedic ward in which elderly patients are treated for hip
fracture does not significantly change the number of
transfusions per patient performed during the LOS.
However, it allows to discharge the patients with signifi-
cantly higher Hb values. In patients undergoing HHA, in
addition to the highest Hb at discharge, the number of
average transfusions per patient is significantly reduced.
The increased values of Hb at discharge and the de-
creased number of transfusions in patients undergoing
HHA indicate the involvement of an orthogeriatrician in
the management of elderly patients with hip fractures.
Indeed, with a higher Hb at discharge, the risk of anemi-
sation of patients is reduced; consequently, also the costs
related to possible re-admission and further transfusions
are reduced.
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